Skip to main content
. 2021 Feb 12;10(2):346. doi: 10.3390/plants10020346

Figure 7.

Figure 7

EC50 and CC50 of resveratrol derivatives against VEEV. Pterostilbene (panel A) and piceatannol (panel B) were used to treat VEEV-TC-83luc (MOI = 0.1)-infected Vero cells at indicated concentrations, followed by measurement of EC50 by viral luciferase activity at 16 h post-infection (C,D). CC50 values were determined (E,F) via quantifying cellular ATP levels. The figures were plotted following the normalizing toward tissue or viral control groups.